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Abstract 24 
 25 
Recombinant gene strategies using fusion tags for purification are essential procedures to obtain 26 
large protein quantities. However, most cloning systems result in recombinant proteins with 27 
added amino acids inexistent in their native forms which can lead to significant changes in protein 28 
properties. An original and simple cloning strategy is proposed to obtain proteins identical in 29 
amino acid sequence to the native proteins. 30 
 31 
 32 
33 
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At present, there is a wide range of cloning vectors available for the overexpression of 34 
recombinant proteins. Medicine, Pharmacy, food industry and most biotechnological industries 35 
are common users of recombinant gene technologies. Cloning and expression systems (CES) 36 
require the insertion of the gene sequence of interest fitting in the right reading frame (Sambrook 37 
et al., 1989). However, during this design, most CES incorporate several additional nucleotides, 38 
from 3 to over 30 bases, resulting in the addition of 1 to over 10 amino acids, respectively. The 39 
addition of amino acid residues to a protein of interest can lead to significant changes in their 40 
properties affecting, for instance, to their stability, antigenic characteristics, and reaction kinetics. 41 
Besides, most of the current commercial CES generate fusion recombinant proteins with a tag 42 
used for simplifying the purification of the recombinant protein. After digestion with specific 43 
proteases (factor Xa, enterokinase among others depending on each CES) the purified protein is 44 
liberated of that tag. Generally, the result is a recombinant protein carrying additional amino acids 45 
absent in its native form. Herein, a novel cloning strategy is proposed which accounts for the use 46 
of  fusion tags and their removal after protein purification, resulting in recombinant proteins with 47 
a primary structure identical to the native proteins. 48 
 49 
An example of the proposed strategy is described using the cloning, expression and purification 50 
system LYTAG Spin Plus Kit (Biomedal, S.L., Seville, Spain) with the vector pAlex2a as the 51 
cloning vector. The plasmid pAlex2a contains a 136 amino acid tag used for rapid protein 52 
purification which is removed by enterokinase digestion. The proposed procedure consists in 53 
introducing a cassette with two recognition sites for class IIS restriction enzymes each one 54 
oriented in opposite directions. Class IIS restriction enzymes recognize asymmetric sequences 55 
and cleave these sequences at a defined distance outside their recognition sites (Szybalski et al., 56 
1991). Because the recognition sites for these restriction enzymes are asymmetric, they can be 57 
oriented in each of the two strains of the DNA so that the cleavage site is engineered as desired. 58 
 4
The insertion of two recognition sites for class IIS restriction enzymes oriented in opposite 59 
directions is a key aspect of the proposed methodology and it aims to external digestions off the 60 
cassette sequence which allows the removal of some additional nucleotides required during the 61 
insertion of the desired gene into the expression vector. 62 
 63 
Figure 1 shows a strategy suggested to modify pAlex2a vector as a representative example to 64 
describe the proposed cloning method. First, a short sequence flanked by two BtgZI recognition 65 
sites must be removed and the plasmid recircularized. This fragment is located downstream of the 66 
multiple cloning site (not shown in Figure 1) and does not affect the cloning and expression of 67 
recombinant proteins using this vector. Second, the resulting plasmid is double digested with 68 
PshAI and EcoRV (which destroys the enterokinase recognition site) and religated. The plasmid 69 
is double digested with BamHI and AscI and the proposed cassette (with overhangs corresponding 70 
to digestions by BamHI and AscI) is ligated into the plasmid resulting in a construct ready to 71 
receive the gene of interest. The designed cassette, besides two BtgZI sites, contains an additional 72 
restriction enzyme recognition site (NdeI) to easily evaluate if the right cloning vector is obtained. 73 
The critical points about the design of this cassette are the sites where the class IIS restriction 74 
enzyme cuts (beyond the 5’ and 3’ sides of the cassette). In this example, after the type IIS 75 
restriction digestion, the enterokinase cleavage site is reestablished and placed just before the start 76 
codon of the cloned gene. A cassette planned for this CES is described in Figure 1. 77 
 78 
The gene of interest can be PCR amplified using a thermostable DNA polymerase with 79 
proofreading activity and two specially designed primers of general use (Figure 1). A 80 
forward primer containing the proposed sequence (5’-C TAG GCG CGC CAC AAG ATG + 81 
target gene sequence) followed by a target sequence corresponding to the beginning of the 82 
gene to be amplified and cloned; its start codon (ATG; bold) is already added to the primer 83 
 5
sequence. For those proteins lacking the ATG start codon (Met), this triplet can be removed.  84 
A restriction site for AscI (underlined) is included for its insertion in the constructed vector. 85 
The reverse primer should contain the proposed sequence followed by the target sequence 86 
corresponding to the ending of the gene of interest (target gene sequence + TGA AGC TTA 87 
GT -3’). This reverse primer includes a HindIII restriction site (underlined) and a stop triplet 88 
(TGA; bold). This design allows cloning between the AscI and HindIII sites of the vector 89 
constructed as described above. A double digestion of the constructed vector and the 90 
amplified gene is followed by a ligation leading to the insertion of the gene. 91 
 92 
Next, the protocol involves a digestion with the type IIS restriction enzyme (BtgZI in this 93 
example) which cuts the construct at two places, both beyond the inserted fragment (Figure 94 
1b). After this digestion and its ligation, the enterokinase cleavage site is reestablished. 95 
Clone overexpression is followed by an easy purification using the LYTAG system included 96 
in this CES. After purification according to the manufacturer instructions, enterokinase 97 
digestion will remove the purification tag and the resulting primary structure of the 98 
recombinant protein will be identical to the native protein of interest (Figure 1b). This 99 
procedure has been successfully applied to produce a recombinant protein corresponding to a 100 
mutant gntR gene from Desulfovibrio vulgaris Hildeborough (Heidelberg et al., 2004). Its 101 
overexpression was not affected by the proposed procedure (Supplementary data Figure S1).  102 
 103 
Once the cloning vector contains the necessary cassette, the cloning is straightforward and 104 
represents a simple protocol which can be easily applied to the cloning and overexpression of 105 
genes from absolutely any source. Different class IIS restriction enzymes can be used to design 106 
appropriate cassettes for different CES as far as the right cutting points are calculated to achieve a 107 
lack of additional nucleotides and the right reading frame for the inserted gene sequence. A few 108 
 6
other examples (among many others) of class IIS restriction enzymes are suggested in Table 1 109 
which can be used to design cloning procedures following the guidelines outlined in this study. 110 
These enzymes can be applied to other vectors and genes and to avoid those enzymes with 111 
recognition sites present in the desired gene sequence. Thus, a variety of CES and vectors can be 112 
used with the proposed procedure. We have designed protocols and cassettes for a variety of high-113 
level expression vectors such as pAlex2a (the example provided in Figure 1)(Biomedal), pGEX 114 
family vectors using GST gene fusion systems (GE Healthcare, Piscataway, NJ, USA) (Example 115 
in Supplementary data Figure S2), and pIEx vector systems with S-tag and His-tag coding 116 
sequences (EMD Biosciences, Darmstadt, Germany). Enterokinase (example of Figure 1) and 117 
other proteases (e.g., Factor Xa in the example of supplementary data Figure S2) used to remove 118 
the tags of the fusion tag recombinant proteins might encounter difficulty to reach their 119 
recognition sites (Shahravan et al., 2008). In these cases protease digestion sites can get buried 120 
inside the recombinant protein structure. This inconvenient can be approached by partial 121 
denaturation (i.e., 1M urea) to produce a more open structure of the fusion tag recombinant 122 
protein (Shahravan et al. 2008) during protease digestion. 123 
 124 
The outlined procedure results in a simple way to design amplification primers for cloning and 125 
recombinant gene expression leading to the production of recombinant proteins with an identical 126 
amino acid sequence to the native molecule. The procedure is highly useful for a broad range of 127 
applications in different fields including medicine, clinical analysis, pharmacy, food industry, and 128 
biotechnology. In this study, a method for the cloning and expression of recombinant proteins is 129 
described. The proposed strategy, besides utilizing the fusion tags for an easy and fast purification 130 
of the recombinant proteins, warrants final recombinant proteins containing identical primary 131 
structures than their native forms.  132 
 133 
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Figure legend 156 
 157 
Figure 1. Schematic representation of the proposed cloning procedure applied to the plasmid 158 
pAlex2a using BtgZI restriction sites in the designed cassette. In A the steps required 159 
to construct a vector containing the cloning cassette are shown. B presents the 160 
procedure to insert a gene of interest in that vector and produce the desired protein 161 
lacking any additional amino acid residue. At the final step, the product obtained after 162 
enterokinase digestion is the recombinant protein with primary structure identical to its 163 
native protein. 164 
165 
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 166 
Table 1. A few examples of commercial class IIS restriction enzymes proposed as 167 
candidates for their use in the design of a cloning procedure such as the one 168 
outlined in this study. These restriction enzymes can be selected as needed 169 
depending on the gene sequence to be cloned and the cloning vector to be used. 170 
 171 
Class IIS 
restriction enzyme 
Recognition and 
cleavage sites 
AlwI 5’-GGATC(N)4 
   CCTAG(N)5 
Alw26I 5’-GTCTC(N)1 
   CAGAG(N)5 
BbsI 5’-GAAGAC(N)2 
   CTTCTG(N)6 
BsgI 5’-GTGCAG(N)16 
   CACGTC(N)14 
BtgZI 5’-GCGATG(N)10 
   CGCTAC(N)14 
Eco57I 5’-CTGAAG(N)16
   GACTTC(N)14
FokI 5’-GGATG(N)9 
   CCTAC(N)13 
KspGUII 5’-CTCTTC(N)1 
   GAGAAG(N)4 
Tth111II 5’-CAARCA(N)11 
   GTTYGT(N)9 
 T
TA
 A
TT
 A
AT
 T
AA
dI
II TT
A 
AT
T
AA
T 
TA
A
II
A 
CC
A 
AG
C 
TT
A 
AT
T
AT
 G
GT
 T
CG
 A
AT
 T
AA
al
 P
ro
 S
er
 L
eu
 I
le
H
in
dI
II
K
pn
I
… 
CC
G 
GT
A 
CC
A 
AG
C
… 
GG
C 
CA
T 
GG
T 
TC
G
H
in
d
K
pn
I
… 
CC
G 
GT
A 
CC
A 
AG
C 
T
… 
GG
C 
CA
T 
GG
T 
TC
G 
A
H
in
dI
K
pn
I
C
lo
ni
ng
 s
ite
s
GC
C 
GA
G 
… 
… 
CC
G 
GT
CG
G 
CT
C 
… 
… 
GG
C 
CA
Al
a 
Gl
u 
… 
… 
Pr
o 
VaK
p
CC
A 
AG
C 
TT
A 
AT
T
GG
T 
TC
G 
AA
T 
TA
A
H
in
dI
II
.
CG
C 
GC
C 
GA
G 
… 
GG
 C
TC
 …
 
GG CC
G 
CG
CAs
cI
O
ve
rh
an
g
GG
C 
GC
G 
CC
G 
AG
 …
 …
CC
G 
CG
C 
GG
C 
TC
 …
 …
A
sc
I
GG
G 
AT
C 
CG
G 
CG
C 
G
CC
C 
TA
G 
GC
C 
GC
G 
C
Gl
y 
Il
e 
Ar
g 
Ar
g 
A
B
am
H
I
A
sc
I
GA
G 
… 
… 
CC
G 
GT
A 
C
CT
C 
… 
… 
GG
C 
CA
T 
G
K
pn
I
n ns
er
tio
n 
of
 th
e 
 c
as
se
tte
A 
TA
T 
GG
C 
GA
T 
GA
C 
T 
AT
A 
CC
G 
CT
A 
CT
G 
N
de
I
B
tg
ZI
TA
T 
GG
C 
GA
T 
GA
C 
G
AT
A 
CC
G 
CT
A 
CT
G 
C
In
se
rte
d 
ca
ss
et
te
N
de
I
B
tg
ZI
A C
 A
TG
 C
TC
 G
AT
 A
TC
 
G 
TA
C 
GA
G 
CT
A 
TA
G 
g 
Me
t 
Le
u 
As
p 
Il
e 
E
co
R
V
G 
AT
C 
CG
G 
CG
C 
GC
C 
C 
TA
G 
GC
C 
GC
G 
CG
G 
B
am
H
I
A
sc
I
an
d 
E
co
R
V
 a
nd
 re
lig
at
io
 B
am
H
I a
nd
 A
sc
I a
nd
 in
  
  
  
  
  
  
  
C 
TA
G 
  
  
  
  
  
G 
AT
C 
GC
A 
TC
G 
CC
A
CG
T 
AG
C 
GG
T
B
am
H
I
O
ve
rh
an
g
B
tg
ZI
ge
ne
 o
f i
nt
er
es
t.
G 
AT
C 
GC
A 
TC
G 
CC
A 
C 
TA
G 
CG
T 
AG
C 
GG
T 
B
tg
ZI
Fi
gu
re
 1
A
AT
 G
AC
 A
AG
 G
GT
 C
GC
TA
 C
TG
 T
TC
 C
CA
 G
CG
sp
 A
sp
 L
ys
 G
ly
 A
rg
P
sh
AI
AT
 G
AC
 A
A-
AT
C 
GG
G
TA
 C
TG
 T
T-
TA
G 
CC
C
sp
 A
sp
B
th
e 
 v
ec
to
r w
ith
 P
sh
AI
 a
ga
tio
n 
po
in
t
e 
cl
ea
va
ge
 
th
e 
 n
ew
 c
on
st
ru
ct
 w
ith
AT
 G
AC
 A
A-
AT
C 
GG
 
TA
 C
TG
 T
T-
TA
G 
CC
C
sp
 A
sp
C
as
se
tte
ga
tio
n 
po
in
t
s 
re
ad
y 
to
 re
ce
iv
e 
 th
e 
g
AT
 G
AC
 A
A-
AT
C 
GG
G
TA
 C
TG
 T
T-
TA
G 
CC
C
sp
 A
sp
ga
tio
n 
po
in
t
GA
T 
GA
C 
GA
CT
A 
CT
G 
CT
As
p 
As
p 
As
GA
T 
GA
C 
GA
CT
A 
CT
G 
CT
As
p 
As
p 
As
D
ig
es
tio
n 
of
 t Li
g
En
te
ro
ki
na
se
D
ig
es
tio
n 
of
  
GA
T 
GA
C 
G A
CT
A 
CT
G 
CT
As
p 
As
p 
AsLig
Th
e 
ve
ct
or
 is
GA
T 
GA
C 
GA
CT
A 
CT
G 
CT
As
p 
As
p 
AsLig
ge
ne
 s
eq
ue
nc
e
H
in
dI
II
AG
C 
TT
A 
AT
T
TC
G 
AA
T 
TA
A
H
in
dI
II
AG
C 
TT
A 
AT
T
TC
G 
AA
T 
TA
A
AT
T
TA
A
AA
G 
AT
G
ta
rg
et
 g
GT
 –
3’
In
se
rte
d 
ge
ne
S
to
p
co
do
n
N 
NN
N 
… 
… 
NN
N 
TG
A
N 
NN
N 
… 
… 
NN
N 
AC
T 
In
se
rte
d 
ge
ne
S
to
p
co
do
n
N 
NN
N 
… 
… 
NN
N 
TG
A
N 
NN
N 
… 
… 
NN
N 
AC
T 
S
ta
rt 
co
do
n
G 
GT
A 
CC
A 
AG
C 
TT
A 
A
 C
AT
 G
GT
 T
CG
 A
AT
 T
H
in
dI
II
K
pn
I
g 
si
te
s
am
pl
ifi
ca
tio
n 
pr
od
uc
t
St
op
 c
od
on
am
pl
ifi
ca
tio
n 
pr
od
uc
t
C 
TA
G 
GC
G 
CG
C 
CA
C 
nc
e 
  
TG
A
AG
C 
TT
A 
G
S
ta
rt
co
do
n
CG
 C
CA
 C
AA
 G
AT
 G
NN
GC
 G
GT
 G
TT
 C
TA
 C
NN
A
sc
I
S
ta
rt
co
do
n
CG
 C
CA
 C
AA
 G
AT
 G
NN
GC
 G
GT
 G
TT
 C
TA
 C
NN
A
sc
I
B
tg
ZI
 c
ut
tin
g 
si
te
A
sc
I
H
in
dI
II
GC
G 
CC
G 
AG
 …
 …
 C
CG
CG
C 
GG
C 
TC
 …
 …
 G
GC
sc
I
C
lo
ni
ng
D
ig
es
te
d 
S
n 
of
 d
ig
es
te
d 
ve
ct
or
 a
nd
 
5’
 –
C
ta
rg
et
 g
en
e 
se
qu
en
ym
e 
B
tg
ZI
st
io
n 
w
ith
 e
nt
er
ok
in
as
e
GG
C 
GA
T 
GA
C 
GG
C 
GC
CC
G 
CT
A 
CT
G 
CC
G 
CGA
tte
B
tg
ZI
GG
C 
GA
T 
GA
C 
GG
C 
GC
CC
G 
CT
A 
CT
G 
CC
G 
CGA
tte
B
tg
ZI
TT AAG
GC
 G
AT
 G
AC
 G
GC
 G
CC
G 
CT
A 
CT
G 
CC
G 
CAs
se
tte
B
tg
ZI
sc
I a
nd
 H
in
dI
II.
 L
ig
at
io
n
th
e 
fo
rw
ar
d 
pr
im
er
:
cI
 a
nd
 H
in
dI
II.
e 
ty
pe
 II
S
 re
st
ric
tio
n 
en
zy
YT
A
G
 s
ys
te
m
 a
nd
 d
ig
es
GC
A 
TC
G 
CC
A 
TA
T 
G
CG
T 
AG
C 
GG
T 
AT
A 
C
ca
ss
et
B
tg
ZI
N
de
I
GC
A 
TC
G 
CC
A 
TA
T 
G
CG
T 
AG
C 
GG
T 
AT
A 
C
ca
ss
et
B
tg
ZI
N
de
I
NN
N 
TG
A
AG
C 
TT
A 
AT
NN
N 
AC
T 
TC
G 
AA
T 
TA
--
-
H
in
dI
II
te
re
stS
to
p
co
do
n
C 
GC
A 
TC
G 
CC
A 
TA
T 
G 
CG
T 
AG
C 
GG
T 
AT
A 
ca
s s
B
tg
ZI
N
de
I
on
st
ru
ct
ed
 v
ec
to
r w
ith
 A
e 
ge
ne
 o
f i
nt
er
es
t u
si
ng
 
rim
er
:
m
pl
ifi
ed
 p
ro
du
ct
 w
ith
 A
s
re
 1
B
ul
tin
g 
co
ns
tru
ct
 w
ith
 th
e
m
bi
na
nt
 p
ro
te
in
 u
si
ng
 L
Y
AC
 A
A-
AT
C 
GG
G 
AT
C 
G 
TT
-
TA
G 
CC
C 
TA
G 
ppo
in
t
AC
 A
A-
AT
C 
GG
G 
AT
C 
G 
TT
-
TA
G 
CC
C 
TA
G 
ppo
in
t
tg
ZI
 c
ut
tin
g 
si
te
C 
AA
G 
AT
G 
NN
N 
..
 N
G 
TT
C 
TA
C 
NN
N 
..
 N
p 
Ly
s 
Me
t 
--
-
..
 -
S
ta
rt
co
do
n G
en
e 
of
 in
t
na
se
si
teAC
 A
A-
AT
C 
GG
G 
AT
C
TG
 T
T-
TA
G 
CC
C 
TA
G
spp
oi
nt
D
ig
es
tio
n 
of
 th
e 
co
A
m
pl
ifi
ca
tio
n 
of
 th
e
an
d 
th
e 
re
ve
rs
e 
pr
D
ig
es
tio
n 
of
 th
e 
am
Fi
gu
D
ig
es
tio
n 
of
 th
e 
re
s
P
ur
ifi
ca
tio
n 
of
 re
co
m
GA
T 
GA
C 
GA
T 
GA
CT
A 
CT
G 
CT
A 
CT
As
p 
As
p 
As
p 
As
Li
ga
tio
n 
p
GA
T 
GA
C 
GA
T 
GA
CT
A 
CT
G 
CT
A 
CT
As
p 
As
p 
As
p 
As
Li
ga
tio
n Bt
GA
T 
GA
C 
GA
T 
GA
C
CT
A 
CT
G 
CT
A 
CT
G
As
p 
As
p 
As
p 
As
p
En
te
ro
ki
n
cu
tti
ng
 s
GA
T 
GA
C 
GA
T 
GA
CT
A 
CT
G 
CT
A 
CT
As
p 
As
p 
As
p 
As
Li
ga
tio
n 
